{
    "score": [
        1.0
    ],
    "extracted": [
        5
    ],
    "abstract": [
        "nanostring technologies inc given consensus rating of `` hold '' by analysts ."
    ],
    "id": "433148.train",
    "article": [
        "shares of nanostring technologies inc have earned an average recommendation of `` hold '' from the seven analysts that are covering the stock , marketbeat . com reports . two equities research analysts have rated the stock with a sell rating , four have issued a hold rating and one has issued a buy rating on the company . the average 12 month price objective among brokerages that have covered the stock in the last year is $ 16.00 . nstg has been the topic of several research analyst reports . robert w. baird dropped their price objective on nanostring technologies from $ 14.00 to $ 12.00 and set an `` outperform '' rating on the stock in a research note on friday , november 3rd . ",
        "zacks investment research cut nanostring technologies from a `` hold '' rating to a `` sell '' rating in a research note on tuesday , october 17th . cowen reissued a `` buy '' rating and issued a $ 20.00 price objective on shares of nanostring technologies in a research note on thursday , september 28th . finally , janney montgomery scott cut nanostring technologies from a `` buy '' rating to a `` neutral '' rating in a research note on thursday , october 12th . nanostring technologies opened at $ 7.85 on tuesday . nanostring technologies has a 52 week low of $ 7.03 and a 52 week high of $ 23.25 . ",
        "the stock has a market capitalization of $ 199.26 , a p/e ratio of -3.79 and a beta of 0.82 . the company has a quick ratio of 2.89 , a current ratio of 3.35 and a debt-to-equity ratio of 1.08 . nanostring technologies last announced its quarterly earnings data on thursday , november 2nd . the biotechnology company reported earnings per share for the quarter , topping the consensus estimate of by $ 0.11 . nanostring technologies had a negative return on equity of 174.55 % and a negative net margin of 44.24 % . the company had revenue of $ 27.02 million for the quarter , compared to analysts ' expectations of $ 26.27 million . ",
        "during the same quarter in the prior year , the firm earned earnings per share . nanostring technologies 's revenue was up 12.9 % compared to the same quarter last year . analysts expect that nanostring technologies will post -1.77 eps for the current year . hedge funds and other institutional investors have recently made changes to their positions in the business . sg americas securities llc bought a new stake in nanostring technologies during the 3rd quarter valued at $ 124,000 . bank of montreal can boosted its position in nanostring technologies by 3,731.4 % during the 2nd quarter . ",
        "bank of montreal can now owns 9,387 shares of the biotechnology company 's stock valued at $ 156,000 after acquiring an additional 9,142 shares in the last quarter . trexquant investment lp bought a new stake in nanostring technologies during the 3rd quarter valued at $ 203,000 . dynamic technology lab private ltd bought a new stake in nanostring technologies during the 3rd quarter valued at $ 222,000 . finally , bank of america corp de boosted its position in nanostring technologies by 16.6 % during the 1st quarter . bank of america corp de now owns 11,404 shares of the biotechnology company 's stock valued at $ 227,000 after acquiring an additional 1,627 shares in the last quarter . ",
        "92.29 % of the stock is currently owned by institutional investors and hedge funds . copyright violation warning : `` nanostring technologies inc given consensus rating of `` hold '' by analysts '' was published by american banking news and is owned by of american banking news . if you are reading this story on another site , it was illegally copied and republished in violation of u. s. & international trademark and copyright legislation . the correct version of this story can be viewed at nanostring technologiesnanostring technologies , inc develops , manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue . ",
        "the company is engaged in the development , manufacture and commercialization of instruments , consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample . receive news & ratings for nanostring technologies daily - enter your email address below to receive a concise daily summary of the latest news and analysts ' ratings for nanostring technologies and related companies with marketbeat . com 's free daily email newsletter .   "
    ]
}